Evidence map›Paper›PMID 27694058›Full record

ArticleNuclear medicine and biology2016

Monooxorhenium(V) complexes with 222-N

Dustin Wayne Demoin, Ashley N Dame, William D Minard, Fabio Gallazzi, Gary L Seickman, Tammy L Rold, Nicole Bernskoetter, Michael E Fassbender, Timothy J Hoffman, Carol A Deakyne and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nuclear medicine and biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Dustin Wayne DemoinDepartment of Chemistry, University of Missouri, Columbia, MO 65211, USA; Research Division, Harry S. Truman Memorial Veteran's Hospital, Columbia, MO 65201, USA.
Ashley N DameDepartment of Chemistry, University of Missouri, Columbia, MO 65211, USA; Research Division, Harry S. Truman Memorial Veteran's Hospital, Columbia, MO 65201, USA.
William D MinardDepartment of Chemistry, University of Missouri, Columbia, MO 65211, USA.
Fabio GallazziDepartment of Structural Biology Core, University of Missouri, Columbia, MO 65211, USA.
Gary L SeickmanResearch Division, Harry S. Truman Memorial Veteran's Hospital, Columbia, MO 65201, USA.
Tammy L RoldDepartment of Medicine, University of Missouri, Columbia, MO 65211, USA; Research Division, Harry S. Truman Memorial Veteran's Hospital, Columbia, MO 65201, USA.
Nicole BernskoetterResearch Division, Harry S. Truman Memorial Veteran's Hospital, Columbia, MO 65201, USA.
Michael E FassbenderChemistry Division, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM 87545, USA.
Timothy J HoffmanDepartment of Chemistry, University of Missouri, Columbia, MO 65211, USA; Department of Medicine, University of Missouri, Columbia, MO 65211, USA; Research Division, Harry S. Truman Memorial Veteran's Hospital, Columbia, MO 65201, USA.
Carol A DeakyneDepartment of Chemistry, University of Missouri, Columbia, MO 65211, USA.
Silvia S JurissonDepartment of Chemistry, University of Missouri, Columbia, MO 65211, USA. Electronic address: jurissons@missouri.edu.
University of Missouri · USHarry S. Truman Memorial Veterans' Hospital · USLos Alamos National Laboratory · US

Funding

Graduate Training in Radiopharmaceutical ChemistryT32EB004822 · NIBIB · UNIVERSITY OF MISSOURI-COLUMBIA · PI JURISSON, SILVIA S. · 2007 to 2011
$744k
BLRD VA I01 BX001699NIBIB NIH HHS T32 EB004822
6 · The paper itself

Abstract

introductionTargeted radiotherapy using the bifunctional chelate approach with

methodsA 222-MAMA chelator, 222-MAMA(N-6-Ahx-OEt) bifunctional chelator, and 222-MAMA(N-6-Ahx-BBN(7-14)NH

resultsAn IC

conclusionsThe

Indexed as

AmidesAminesAnimalsCell Line, TumorChelating AgentsChemistry Techniques, SyntheticDrug StabilityLigandsMiceOrganometallic CompoundsRheniumTissue DistributionTolueneAmidesAminesChelating AgentsdithiolLigandsOrganometallic CompoundsRheniumTolueneBombesinMAMA ligandsQuantum chemical studiesRadiotherapyRhenium-186Rhenium(V)

Identifiers

PMID27694058
PMCPMC5118109
OpenAlexW2517660041

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.